At a Glance
- Founded: 1997, headquartered in Berlin, Germany
- Management: Prof. Dr. Hoda Tawfik (COO and Co-CEO), Christian von Volkmann (CFO and Co-CEO)
- Employees: 18 employees as well as a production company with 8 employees
- Listed on Frankfurt Stock Exchange, (MF6)
- Strong IP protection: 17 international patent families, approx. 100 single patents and 65 patent applications
- Product launch of NanoTherm® therapy in 2011
Recent Highlights
- Establishment of the first NanoTherm® therapy treatment center at the Charite-Universitätsmedizin Berlin, Clinic for Radiooncology, Campus Virchow
- Successful completion of efficacy study in patients with recurrent glioblastoma
- Publication of study results in the Journal of Neuro-Oncology
- European regulatory approval of the NanoTherm® therapy (CE European conformity marking)
- Equity funding of approx € 24 million ($31 million) secured in 2010
- Distribution agreement signed with DELRUS, a leading Russian medical devices distribution company, for market entry in Russia and TekGrup, a leading company for sales, after sales services and support of medical devicesfor market entry in Turkey, Iraq, Albania and Azerbaijan
